Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| SPRUCE BIOSCIENCES, INC. | 11,000 | reported | 09 Mar 2026 | tx 1+11,000 |
| Clovis Oncology, Inc. | 4,688 | reported | 05 Sept 2018 | tx 36+121,962−18,570 |
| Applied Therapeutics, Inc. | 0 | reported | 03 Feb 2026 | tx 5+862,500−868,253 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Mar 2026 | GRANT_AWARD | SPRUCE BIOSCIENCES, INC. | 11,000 | 0.00 USD | deriv |
| 19 Dec 2025 | GRANT_AWARD | Applied Therapeutics, Inc. | 312,500 | 0.00 USD | |
| 03 Feb 2026 | OTHER | Applied Therapeutics, Inc. | 862,500 | — | |
| 03 Feb 2026 | TENDER | Applied Therapeutics, Inc. | 5,753 | — | |
| 24 Mar 2025 | GRANT_AWARD | Applied Therapeutics, Inc. | 250,000 | 0.00 USD | |
| 12 Apr 2024 | GRANT_AWARD | Applied Therapeutics, Inc. | 300,000 | 0.00 USD | |
| 31 Aug 2017 | SALE | Clovis Oncology, Inc. | 2,150 | 76.36 USD | |
| 15 Jun 2018 | SALE | Clovis Oncology, Inc. | 939 | 45.47 USD | |
| 05 Sept 2018 | EXERCISE | Clovis Oncology, Inc. | 469 | — | |
| 05 Sept 2018 | TAX_WITHHOLDING | Clovis Oncology, Inc. | 239 | 35.75 USD | |
| 05 Sept 2018 | EXERCISE | Clovis Oncology, Inc. | 469 | 0.00 USD | deriv |
| 27 Aug 2018 | TAX_WITHHOLDING | Clovis Oncology, Inc. | 434 | 35.15 USD | |
| 27 Aug 2018 | EXERCISE | Clovis Oncology, Inc. | 869 | — | |
| 27 Aug 2018 | EXERCISE | Clovis Oncology, Inc. | 869 | 0.00 USD | deriv |
| 06 Jun 2018 | EXERCISE | Clovis Oncology, Inc. | 468 | — | |
| 06 Jun 2018 | TAX_WITHHOLDING | Clovis Oncology, Inc. | 235 | 47.70 USD | |
| 06 Jun 2018 | EXERCISE | Clovis Oncology, Inc. | 468 | 0.00 USD | deriv |
| 31 May 2018 | TAX_WITHHOLDING | Clovis Oncology, Inc. | 444 | 48.63 USD | |
| 31 May 2018 | EXERCISE | Clovis Oncology, Inc. | 869 | — | |
| 31 May 2018 | EXERCISE | Clovis Oncology, Inc. | 869 | 0.00 USD | deriv |
| 07 Mar 2018 | TAX_WITHHOLDING | Clovis Oncology, Inc. | 938 | 58.43 USD | |
| 07 Mar 2018 | EXERCISE | Clovis Oncology, Inc. | 1,875 | — | |
| 07 Mar 2018 | EXERCISE | Clovis Oncology, Inc. | 1,875 | 0.00 USD | deriv |
| 01 Mar 2018 | TAX_WITHHOLDING | Clovis Oncology, Inc. | 467 | 55.51 USD | |
| 01 Mar 2018 | EXERCISE | Clovis Oncology, Inc. | 869 | — |